NIH Clinical Trial Supported by CTSA Program Hubs Shows Improved Survival for People Hospitalized with COVID-19
Preliminary results from the ACTIV-1 Immune Modulator clinical trial show that immune modulator drugs, infliximab and abatacept, substantially improved clinical status and reduced death
Duke CTSI Announces MURDOCK Biorepository Initiative for Investigators
The Duke Clinical and Translational Science Institute (CTSI) has announced a new opportunity for Duke investigators to obtain biospecimens from the MURDOCK Study for research.
Duke CTSI Community Engaged Research Initiative (CERI) Announces 2022-23 Population Health Improvement Awards Recipients
The Duke CTSI Community Engaged Research Initiative (CERI) team is delighted to announce the recipients of its 2022-23 Population Health Improvement Awards. These annua
An Injectable Alternative for Treating Uterine Fibroids
Three Scholars Selected for 2022 CTSA TL1 Pre-Doctoral Training Program
Three new scholars have been accepted to the Duke CTSA TL1 Pre-Doctoral Training Program.
Three DSMM Scholars Selected for 2022 Borden Scholarship
Three scholars have been selected for this year’s Borden Scholarship: Jacob Heggestad, Chin Yee Tan, and Wenxin Tong.
Duke NCSP Scholar Published in Journal of the American Geriatrics Society
NCCU Ethnodrama Team Published in Journal of Cervical Cancer Research
In February, research team members at North Carolina Central University (NCCU) were published in the Journal of Cervical Cancer Research, highlighting their use of ethnodramas